FAYEZ SAROFIM & CO - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
FAYEZ SAROFIM & CO ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$6,553,672
-44.7%
64,340
-45.2%
0.02%
-47.6%
Q2 2023$11,856,925
-45.4%
117,500
-50.3%
0.04%
-44.7%
Q1 2023$21,734,540
-30.9%
236,245
-31.8%
0.08%
-34.5%
Q4 2022$31,437,201
+9.5%
346,530
-8.3%
0.12%
+2.7%
Q3 2022$28,720,000
-16.0%
377,845
-6.6%
0.11%
-9.6%
Q2 2022$34,178,000
-6.2%
404,331
-2.7%
0.12%
+8.7%
Q1 2022$36,447,000
+1.3%
415,356
+1.0%
0.12%
+6.5%
Q4 2021$35,968,000
+9.4%
411,200
+2.2%
0.11%
-0.9%
Q3 2021$32,888,000
-13.0%
402,154
-2.9%
0.11%
-14.2%
Q2 2021$37,797,000
+3.5%
414,271
-3.0%
0.13%
-5.2%
Q1 2021$36,519,000
-8.8%
427,225
+0.8%
0.13%
-13.0%
Q4 2020$40,025,000
+8.2%
423,855
-0.4%
0.15%
-3.1%
Q3 2020$37,007,000
-3.1%
425,555
-2.7%
0.16%
-9.7%
Q2 2020$38,194,000
+6.0%
437,305
+0.0%
0.18%
-20.7%
Q1 2020$36,047,000
-13.6%
437,205
-0.8%
0.22%
+10.4%
Q4 2019$41,740,000
+7.2%
440,798
-1.6%
0.20%0.0%
Q3 2019$38,929,000
-5.9%
447,965
-1.2%
0.20%
-6.1%
Q2 2019$41,388,000
-3.9%
453,265
+1.2%
0.21%
-5.7%
Q1 2019$43,077,000
+6.3%
448,075
-5.1%
0.23%
-7.0%
Q4 2018$40,505,000
-11.6%
472,041
-11.3%
0.24%
+2.1%
Q3 2018$45,832,000
-29.5%
531,943
-38.2%
0.24%
-31.7%
Q2 2018$64,984,000
-39.0%
860,262
-34.7%
0.35%
-39.3%
Q1 2018$106,564,000
-6.1%
1,318,046
-2.4%
0.58%
-1.9%
Q4 2017$113,428,000
-8.3%
1,350,964
-6.2%
0.59%
-9.5%
Q3 2017$123,645,000
+2.6%
1,440,246
-0.3%
0.65%
+0.9%
Q2 2017$120,555,000
+9.8%
1,444,293
-2.3%
0.64%
+7.7%
Q1 2017$109,787,000
+0.8%
1,478,201
-1.1%
0.60%0.0%
Q4 2016$108,910,000
-11.4%
1,495,200
-3.9%
0.60%
-10.6%
Q3 2016$122,891,000
-7.4%
1,556,255
-3.2%
0.67%
-8.0%
Q2 2016$132,656,000
+20.0%
1,607,219
+5.1%
0.73%
+14.7%
Q1 2016$110,559,000
-14.8%
1,529,421
+1.3%
0.63%
-15.1%
Q4 2015$129,833,000
-6.3%
1,509,765
+0.1%
0.75%
-6.6%
Q3 2015$138,602,000
-1.2%
1,507,914
+5.8%
0.80%
+12.0%
Q2 2015$140,254,000
-6.3%
1,425,736
-5.9%
0.71%
-2.7%
Q1 2015$149,727,000
+19.2%
1,514,777
+11.7%
0.73%
+23.2%
Q4 2014$125,618,000
+16.5%
1,356,658
+18.2%
0.60%
+18.3%
Q3 2014$107,854,000
+5.8%
1,147,992
+2.2%
0.50%
+8.2%
Q2 2014$101,895,000
+8.5%
1,123,133
+1.6%
0.47%
+4.3%
Q1 2014$93,902,000
+4.8%
1,105,904
-0.8%
0.45%
+7.5%
Q4 2013$89,568,000
+56.1%
1,114,308
+37.3%
0.42%
+44.4%
Q2 2013$57,386,000811,5760.29%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders